TMS-007 is designed to restore blood flow following acute stroke, with an extended treatment window versus current standard of care Biogen to pay $4 million upfront and $18 million upon exercise of ...

Biogen has licensed a new drug from Japanese biotech TMS that it hopes could provide a big advance on an old treatment approach – using clot-busting thrombolytic drugs to treat ischaemic stroke. The ...

Biogen Inc and TMS Co Ltd, a? clinical stage biotechnology company, announced that Biogen exercised its option to acquire TMS-007, an investigational drug for acute ischemic stroke, from TMS. Biogen’s ...

(RTTNews) - Neuroscience company Biogen Inc (BIIB) announced Wednesday that it has exercised its option to acquire TMS-007, an investigational drug for acute ischemic stroke, from privately-held ...

TMS Co., Ltd. (JP:4891) has released an update. TMS Co., Ltd., a clinical-stage biopharmaceutical company, is making strides with its promising lead program, TMS-007, aimed at treating acute ischemic ...

Acute ischemic stroke is typically treated with drugs that dissolve blood clots but these therapies bring the risk of a potentially deadly complication. An experimental drug from Japan-based TMS Co.

CAMBRIDGE, Mass. and FUCHU-SHI, Tokyo, May 12, 2021 (GLOBE NEWSWIRE) -- Biogen Inc (Nasdaq: BIIB) and TMS Co., Ltd. announced today that Biogen exercised its option to acquire TMS-007, an ...

Biogen signed a deal for an exclusive chance to acquire TMS’ treatment for restoring blood flow after acute ischemic stroke, which is currently being evaluated in a placebo-controlled phase 2 study in ...

Biogen Inc. said Thursday it has entered an exclusive option agreement with TMS Co. Ltd. to acquire its TMS-007 treatment for acute stroke. The company said it will pay $4 million upfront and an ...

Transcranial magnetic stimulation (TMS) has shown significant efficacy in treating major depressive and obsessive compulsive disorders. A newly published literature review by Antonio H. Iglesias, MD, ...

Use of inhibitory transcranial magnetic stimulation (TMS) over the speech area in the right side of the brain significantly improved language recovery in patients with stroke, new research shows. "The ...